Markowitz, John S.

Atypical Antipsychotics Part I: Pharmacology, Pharmacokinetics, and Efficacy

Markowitz, J. S., Brown, C. S., & Moore, T. R. (1999) · Annals of Pharmacotherapy

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 208

Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana

Zhu, H.-J., Wang, J.-S., Markowitz, J. S., Donovan, J. L., Gibson, B. B., Gefroh, H. A., & DeVane, C. L. (2006) · The Journal of Pharmacology and Experimental Therapeutics

Drug Transport and Resistance MechanismsCannabis and Cannabinoid Research

Cited by 192

Pharmacokinetic and Pharmacodynamic Drug Interactions in the Treatment of Attention-Deficit Hyperactivity Disorder

Markowitz, J. S., & Patrick, K. S. (2001) · Clinical Pharmacokinetics

Attention Deficit Hyperactivity DisorderPharmacogenetics and Drug Metabolism

Cited by 123

A Comprehensive In Vitro Screening of d-, l- , and dl-threo -Methylphenidate: An Exploratory Study

Markowitz, J. S., DeVane, C. L., Pestreich, L. K., Patrick, K. S., & Muniz, R. (2006) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 109

An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram

Markowitz, J. S., DeVane, C. L., Liston, H. L., & Montgomery, S. A. (2000) · International Clinical Psychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 34

Rifampin‐induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertraline

Markowitz, J. S., & DeVane, C. L. (2000) · Journal of Clinical Psychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 34